SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-021758
Filing Date
2023-06-09
Accepted
2023-06-09 17:04:52
Documents
14
Period of Report
2023-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20230607.htm   iXBRL 8-K 56118
2 EX-10.1 exhibit101bioventusinc2023.htm EX-10.1 110552
3 EX-10.2 exhibit102formofrestricted.htm EX-10.2 42751
  Complete submission text file 0001628280-23-021758.txt   387116

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20230607.xsd EX-101.SCH 1904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20230607_lab.xml EX-101.LAB 25850
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20230607_pre.xml EX-101.PRE 13584
8 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20230607_htm.xml XML 11449
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 231006203
SIC: 3841 Surgical & Medical Instruments & Apparatus